Interact to see
Advertisement
Advertisement
RSEGX vs VEXRX
RSEGX vs VEXRX Comparison
Open Charts RSEGX vs VEXRX
Victory RS Small Cap Growth A
Price$57.56
Change-$0.53 (-0.91%)
VolumeN/A
Net Assets399.67M
Vanguard Explorer Adm
Price$112.05
Change-$1.34 (-1.18%)
VolumeN/A
Net Assets20.56B
RSEGX vs VEXRX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
VS
RSEGX vs. VEXRX commentary
Oct 08, 2025
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RSEGX is a Hold and VEXRX is a Hold.
FUNDAMENTALS
Fundamentals
VEXRX has more cash in the bank: 20.6B vs. RSEGX (400M). VEXRX pays higher dividends than RSEGX: VEXRX (0.49) vs RSEGX (0.00). RSEGX was incepted earlier than VEXRX: RSEGX (38 years) vs VEXRX (24 years). RSEGX (1.41) is less costly to investors than VEXRX (0.33). RSEGX is a more actively managed with annual turnover of: 120.00 vs. VEXRX (35.00). RSEGX has a lower initial minimum investment than VEXRX: RSEGX (2500) vs VEXRX (50000). RSEGX annual gain was more profitable for investors over the last year : 1.63 vs. VEXRX (0.86). VEXRX return over 5 years is better than : 6.16 vs. RSEGX (-36.82).
| RSEGX | VEXRX | RSEGX / VEXRX | |
| Total Expense Ratio | 1.40 | 0.33 | 424% |
| Annual Report Gross Expense Ratio | 1.41 | 0.33 | 427% |
| Fund Existence | 38 years | 24 years | - |
| Gain YTD | -0.292 | 6.121 | -5% |
| Front Load | 6% | N/A | - |
| Min. Initial Investment | 2500 | 50000 | 5% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 400M | 20.6B | 2% |
| Annual Yield % from dividends | 0.00 | 0.49 | - |
| Returns for 1 year | 1.63 | 0.86 | 190% |
| Returns for 3 years | 23.28 | 29.48 | 79% |
| Returns for 5 years | -36.82 | 6.16 | -598% |
| Returns for 10 years | -12.55 | 35.02 | -36% |
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| PIEIX | 34.86 | N/A | N/A |
| Principal Glb Emerging Markets Inst | |||
| ETIHX | 42.42 | N/A | N/A |
| Eventide Healthcare & Life Sciences I | |||
| ENHNX | 10.33 | N/A | N/A |
| Cullen Enhanced Equity Income I | |||
| LICOX | 18.69 | N/A | N/A |
| Lord Abbett International Equity F3 | |||
| RGABX | 78.57 | -0.51 | -0.64% |
| American Funds Growth Fund of Amer R2 | |||